Economic development and revolutions. A cross-national investigation
Conflict Management and Peace Science · 21.04.2026
DOI: 10.1177/07388942261442041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Conflict Management and Peace Science, online erschienen am 21.04.2026. Verfasst von Vadim Ustyuzhanin und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
In the field of civil war studies, there is a consensus that the risk of war decreases as income increases. Nevertheless, such consensus has not been reached in the field of civil resistance and unarmed revolutions. This paper proposes a curvilinear framework positing two opposite trends in economic development. On the one hand, it increases the state resources for preventing illegal displacement and makes revolt costly for rebels. Conversely, it boosts resources needed for civil resistance. Utilizing independent sources on revolutions and employing parametric and non-parametric methods, we have identified robust support for the inverted “U-shape” relationship between income level and the risk of unarmed revolutions. This finding reconciles the discrepancies observed in previous studies and provides a different perspective on the “middle-income trap.”
Förderung
- Russian Science Foundation
Zitieren
APA
Ustyuzhanin, V., Fain, E., & Korotayev, A. (2026). Economic development and revolutions. A cross-national investigation. Conflict Management and Peace Science. https://doi.org/10.1177/07388942261442041
Vancouver
Ustyuzhanin V, Fain E, Korotayev A. Economic development and revolutions. A cross-national investigation. Conflict Management and Peace Science. 2026. doi:10.1177/07388942261442041
BibTeX
@article{Ustyuzhanin2026,
author = {Ustyuzhanin, Vadim and Fain, Egor and Korotayev, Andrey},
title = {Economic development and revolutions. A cross-national investigation},
journal = {Conflict Management and Peace Science},
year = {2026},
doi = {10.1177/07388942261442041}
}
EUVIMED